Acquisition of Encorafenib 75 mg Capsules
About This Opportunity
TranslatedThis tender pertains to the procurement of Encorafenib 75 mg capsules, a medication used in the treatment of specific types of cancer. The primary objective of this tender is to ensure a reliable supply of this essential pharmaceutical product to healthcare facilities. Interested suppliers are expected to demonstrate their capability to meet the required quality standards and provide the medication in a timely manner. Key requirements include compliance with regulatory standards for pharmaceutical products, competitive pricing, and the ability to deliver the medication to designated locations within the specified timeframe. The tender is open to qualified pharmaceutical manufacturers and distributors who can provide evidence of their experience in supplying similar products. It is crucial for bidders to submit all necessary documentation, including certifications and proof of previous contracts, to validate their qualifications. This procurement is critical for enhancing treatment options available to patients and ensuring that healthcare providers have access to the necessary medications for effective cancer management. The location for delivery will be specified in the tender documents, and bidders are encouraged to review all terms and conditions carefully before submitting their proposals.
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 40,427.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "Aquisição do Medicamento Encorafenib 75 mg cápsulas" pertains to the procurement of Encorafenib, a targeted therapy medication used primarily in the treatment of specific types of cancer.
This procurement initiative is set within Portugal, where the contracting authority is responsible for ensuring that healthcare providers have access to essential medications that meet the therapeutic needs of patients.
The successful bidder will be required to supply Encorafenib in 75 mg capsule form, adhering to the stringent quality standards mandated by health authorities. This tender is indicative of the broader objective to enhance the availability of innovative cancer treatments within the Portuguese healthcare system, ensuring that patients receive timely and effective care.
Typical requirements for this type of tender include the provision of comprehensive product documentation, including certificates of analysis, compliance with Good Manufacturing Practices (GMP), and evidence of regulatory approval from relevant health authorities. Bidders may also be expected to demonstrate their capacity for timely delivery and adherence to specified storage conditions to maintain the integrity of the medication.
In addition to product specifications, bidders should be prepared to outline their pricing structures, including any volume discounts or contractual terms that may apply. The tender process is facilitated through the Portal BASE, which centralizes public contract information in Portugal, ensuring transparency and accessibility for all stakeholders involved in the procurement process.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 23, 2026. Last refreshed 5 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde da Cova da Beira, EPE
Unidade Local de Saúde da Cova da Beira, EPE has issued 135 procurement notices on BidsFactory, including 3 currently open and 107 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €40,427. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to PIERRE FABRE MÉDICAMENT PORTUGAL, LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde da Cova da Beira, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.